Search research articles
Contact Us
Filters
Showing results (71-80 of 234) with videos related to
Page
of 24
Sort By:
The Journal of Nutrition
|
June 3, 2005
Mechanisms of action and antiproliferative properties of Brassica oleracea juice in human breast cancer cell lines
Giorgio Brandi, Giuditta F Schiavano, Nadia Zaffaroni, et al.
Cell Death & Disease
|
November 27, 2022
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, et al.
Colloids and Surfaces. B, Biointerfaces
|
June 14, 2013
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells
Raffaella Villa, Barbara Cerroni, Lucia Viganò, et al.
Frontiers in Cell and Developmental Biology
|
August 6, 2020
Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells
Cristina Corno, Noemi Arrighetti, Emilio Ciusani, et al.
European Journal of Medicinal Chemistry
|
October 14, 2022
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy
Jessica Caciolla, Silvia Martini, Angelo Spinello, et al.
The Journal of Pathology
|
September 5, 2002
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity
Nadia Zaffaroni, Chiara Della Porta, Raffaella Villa, et al.
Journal of Hematology & Oncology
|
January 20, 2017
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
Rihan El Bezawy, Michelandrea De Cesare, Marzia Pennati, et al.
Scientific Reports
|
January 14, 2018
A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers
Matic Pavlin, Angelo Spinello, Marzia Pennati, et al.
International Journal of Cancer
|
April 25, 2003
Role of proliferation in HER2 status predicted response to doxorubicin
Manuela Campiglio, Giulia Somenzi, Clelia Olgiati, et al.
Carcinogenesis
|
May 29, 2003
Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells
Raffaella Villa, Marco Folini, Chiara Della Porta, et al.
Page
of 24
Search research articles
Search
Showing results (71-80 of 234) with videos related to
Sort By:
Page
of 24
The Journal of Nutrition
|
June 3, 2005
Mechanisms of action and antiproliferative properties of Brassica oleracea juice in human breast cancer cell lines
Giorgio Brandi, Giuditta F Schiavano, Nadia Zaffaroni, et al.
Cell Death & Disease
|
November 27, 2022
Teloxantron inhibits the processivity of telomerase with preferential DNA damage on telomeres
Natalia Maciejewska, Mateusz Olszewski, Jakub Jurasz, et al.
Colloids and Surfaces. B, Biointerfaces
|
June 14, 2013
Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells
Raffaella Villa, Barbara Cerroni, Lucia Viganò, et al.
Frontiers in Cell and Developmental Biology
|
August 6, 2020
Synergistic Interaction of Histone Deacetylase 6- and MEK-Inhibitors in Castration-Resistant Prostate Cancer Cells
Cristina Corno, Noemi Arrighetti, Emilio Ciusani, et al.
European Journal of Medicinal Chemistry
|
October 14, 2022
Single-digit nanomolar inhibitors lock the aromatase active site via a dualsteric targeting strategy
Jessica Caciolla, Silvia Martini, Angelo Spinello, et al.
The Journal of Pathology
|
September 5, 2002
Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity
Nadia Zaffaroni, Chiara Della Porta, Raffaella Villa, et al.
Journal of Hematology & Oncology
|
January 20, 2017
Antitumor activity of miR-34a in peritoneal mesothelioma relies on c-MET and AXL inhibition: persistent activation of ERK and AKT signaling as a possible cytoprotective mechanism
Rihan El Bezawy, Michelandrea De Cesare, Marzia Pennati, et al.
Scientific Reports
|
January 14, 2018
A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers
Matic Pavlin, Angelo Spinello, Marzia Pennati, et al.
International Journal of Cancer
|
April 25, 2003
Role of proliferation in HER2 status predicted response to doxorubicin
Manuela Campiglio, Giulia Somenzi, Clelia Olgiati, et al.
Carcinogenesis
|
May 29, 2003
Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells
Raffaella Villa, Marco Folini, Chiara Della Porta, et al.
Page
of 24